Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Julphar
Cipla
UBS
Baxter
Federal Trade Commission

Generated: March 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pheniramine

« Back to Dashboard

US Patents for Pheniramine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pheniramine ➤ Sign Up Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA) ➤ Sign Up
Pheniramine ➤ Sign Up Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof ➤ Sign Up
Pheniramine ➤ Sign Up Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation Alcon Laboratories, Inc. (Fort Worth, TX) ➤ Sign Up
Pheniramine ➤ Sign Up Process for solubilizing difficulty soluble pharmaceutical actives Richrdson-Vicks Inc. (Shelton, CT) ➤ Sign Up
Pheniramine ➤ Sign Up Method for determining amount of medication in an implantable device Allergan, Inc. (Irvine, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Pheniramine

Drugname Country Document Number Estimated Expiration Related US Patent
Pheniramine Australia 2014232383 2033-03-15 ➤ Sign Up
Pheniramine Brazil 112015023267 2033-03-15 ➤ Sign Up
Pheniramine Canada 2906931 2033-03-15 ➤ Sign Up
Pheniramine China 105142635 2033-03-15 ➤ Sign Up
Pheniramine Eurasian Patent Organization 201591607 2033-03-15 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
Fish and Richardson
Boehringer Ingelheim
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.